The Hirshberg Foundation for Pancreatic Cancer Research is pleased to welcome Dr. Mark D. Girgis as the new Director of the UCLA Agi Hirshberg Center for Pancreatic Diseases. As Director […]
First RAS inhibitor approved by the FDA
Today daraxonrasib, an oral RAS(ON) multi-selective inhibitor from Revolution Medicines, was approved by the FDA for use by patients with previously treated metastatic pancreatic ductal adenocarcinoma (PDAC) or for patients […]
Healing After Loss: A New Support Group for Families Grieving Pancreatic Cancer
The journey through pancreatic cancer does not end when treatment does. For many families, the loss of a loved one marks the beginning of a new chapter filled with grief, […]
Supporting a Loved One After Pancreas Surgery
Caring for someone going through pancreatic cancer surgery is an act of deep compassion, and it can also feel overwhelming. From managing appointments to supporting recovery at home, caregivers play […]
The Power of Emotional Support During Pancreatic Cancer Treatment
Pancreatic cancer treatment is physically demanding, and the emotional impact can be just as significant. From diagnosis through recovery, patients often experience a wide range of emotions, including fear, anxiety, […]
Increasing Survival Through Early Detection
At the 20th Annual Hirshberg Symposium, Dr. Margaret Tempero, the Director of the Cancer Early Detection and Interception Initiative and the leader of the Pancreas Center Program at the UCSF […]